Cookies Policy
We use cookies to improve our site and your experience. By continuing to browse our site you accept our cookie policy. Find out More
Close
  • Menu
Description

Image Analysis and Machine Learning Platform for Innovation in Diabetic Retinopathy Screening

The North of Portugal Health Administration is implementing a mass screening for diabetic retinopathy (DR). The goal is to perform an eye exam on about 75% of identified diabetics. The goal of the SCREEN-DR consortium is to create a distributed and automatic screening platform for DR, based on PACS management, Machine Learning and Image Analysis, enabling an immediate response from health carers, allowing accurate follow-up strategies, and fostering technological innovation. The main objectives are: automatically assessing image quality, automatically detecting and grading diabetic retinopathy, which can be mild non-proliferative, moderate/severe non-proliferative and proliferative.

Details

Details

  • Acronym

    SCREEN-DR
  • Start

    01st April 2016
  • Global Budget

    552.054,00 €
    Team
    002

    Associated Centres

    C-BER

    Centre

    Biomedical Engineering Research

    CITE

    Centre

    Innovation, Technology and Entrepreneurship